Bill Milgram Ph.D.
Chief Scientific Officer

Dr. Milgram is a co-founder of CanCog and the world's leading expert in the field of canine cognitive aging. He was instrumental in the successful development of Anipryl as an animal pharmaceutical licensed to Pfizer for treatment of Cognitive Dysfunction Syndrome in Dogs. More recently, Dr. Milgram has assisted in the development of the ProPlan Senior 7+ diet for dogs, Nutricks (cognitive dysfunction) and Sin Susto as an anxiolytic. Dr. Milgram's scientific qualification include over 150 refereed publications, over 100 abstracts, 2 edited books and 8 book chapters. He has also been a consultant to several animal health and pet food companies. Dr. Milgram has a PhD in behavioral Neuroscience from McGill University, is a professor emeritus at the University of Toronto and currently holds an appointment in the department of Pharmacology at the University of Toronto.

Gary Landsberg D.V.M., Dip. ACVB
Vice President

Dr. Landsberg is a board certified veterinary behaviorist, in both the American College of Veterinary Behaviorists and the European College of Veterinary Behavioural Medicine. When not at CanCog, he continues to see canine and feline behavior cases on a referral basis. He publishes, studies, researches and lectures extensively in field of veterinary behavior and has a special interest in canine and feline cognitive dysfunction. He is also the author of a clinical textbook in canine and feline behavior. As director of veterinary affairs, Dr. Landsberg aids in the development of new models for canine and feline behavior disorders and also serves as project coordinator for therapeutic trials.

Stephanie Kelly BSc.
Scientific Director

Stephanie Kelly holds a Bachelor of Science degree with honours majoring in Animal Biology and has over 8 years of experience coordinating research trials related to animal and human health. Stephanie gained extensive experience with laboratory animals as a Research Technician III and Study Coordinator, where she organized and implemented pre-clinical trials for pharmacokinetics, efficacy and model development studies. In 2016, Stephanie continued her education by completing a Clinical Research Graduate Certificate and expanded her experience to clinical research coordination focused in pet nutrition. As Scientific Director, Stephanie aids in study design and execution of trials in companion animals to assess pet foods, nutraceuticals and drug efficacy. Her main area of interest lies in cognition and anxiety and she is dedicated to the advancement of animal and human wellness through quality science and innovation.